Argus
•
May 27, 2026
TNDM: Raising target price to $13.00
Summary
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
The Argus Sustainable Growth Theme Model Portfolio
May 28, 2026
•
TT, GOOGL, DE, AAPL, NDAQ, AVGO, ADI, JPM, JNJ, MRK, TXN, MSFT, TFC, GLW, MA, LLY, TRV, SPGI, GE, NVDA, NOC, KO, KMI, AEP, GS, ECL, TMUS, ETN, AMZN, WMT
Analyst Report: Insulet Corporation
May 27, 2026
•
PODD
ARWR: Raising target price to $83.00
May 27, 2026
•
ARWR
TGTX: Raising target price to $44.00
May 27, 2026
•
TGTX
SRPT: What does Argus have to say about SRPT?
May 27, 2026
•
SRPT
